IsomAb makes two key appointments; Dr Shi Yin Foo M.D. as Non-Executive Director and Dr Gary Burgess M.D. as Chief Medical Officer
IsomAb Ltd, a UK-based biotechnology company developing novel isoform-specific disease modifying antibody treatments, for peripheral arterial disease and other ischaemic conditions, today announced ...
kffhealthnews34m
Elizabeth Holmes’ Blood-Testing Fraud Conviction Upheld By Appeals Court
She claimed that her company, Theranos, could run accurate and fast tests from blood drawn from a finger prick. She was convicted of fraud in 2022, and the ruling was upheld Monday by a federal ...